MENU
ABCL
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

AbCellera Biologics (ABCL) Earnings Date & Reports

AbCellera Biologics Inc is an antibody discovery and development engine that’s specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner... Show more

A.I. Advisor
published Earnings

ABCL is expected to report earnings to fall 26.95% to -13 cents per share on February 24

AbCellera Biologics ABCL Stock Earnings Reports
Q4'25
Est.
$-0.14
Q3'25
Missed
by $0.05
Q2'25
Beat
by $0.02
Q1'25
Missed
by $0.01
Q4'24
Beat
by $0.01
The last earnings report on November 06 showed earnings per share of -18 cents, missing the estimate of -14 cents. With 4.37M shares outstanding, the current market capitalization sits at 1.18B.
View a ticker or compare two or three
ABCL
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. ABCL showed earnings on November 06, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
2215 Yukon Street
Phone
+1 604 559-9005
Employees
586
Web
https://www.abcellera.com